North Texas I&I Chemical Manufacturer, 38-Year Wholesale Blender & Co-Packer

$5.1M

Revenue

$1.1M

SDE

6.4x

Multiple

Subscribe Free

Read the full deal writeup

Get Free Access

Already a member? Sign in

Full Editorial Writeup

This is a 38-year-old wholesale manufacturer of institutional and industrial (I&I) liquid and powder cleaning compounds based in Dallas, Texas. The company sells through authorized distributors who supply laundry, food service, housekeeping, industrial, oilfield, and car wash end markets nationwide. Revenue flows through three channels: proprietary branded product lines sold exclusively through distributors, custom blending and co-packing under national brands' private labels, and a word-of-mouth plus tradeshow network. Daily production capacity exceeds 10,000 gallons of liquid blends and 10,000 pounds of powder compounds.

The revenue mix is genuinely diversified across end markets: roughly 30% food service, 20-25% commercial laundry, 15-20% car-transport wash, 15% oilfield (growing fast), and 10% industrial. The company served about 114 active accounts in 2025, with top-10 customers averaging 13-plus year relationships and several exceeding 30 years. Concentration is moderate: top 10 represent about 68% of revenue with the largest single account at 14.4%. Stickiness is reinforced by proprietary formulations, custom private-label packaging, and decades of personal service relationships that are hard to replicate quickly.

The standout dynamic here is consolidation. Two significant I&I chemical competitors exited the market in 2024-2025, and this company is absorbing their orphaned distributor accounts at minimal incremental cost. The business runs at or near full capacity on a single shift out of a 23,000 SF facility that performs like a 40,000+ SF building thanks to 25-foot clear heights. There is a clear path to roughly double output by adding a second shift with no facility capital, plus land for an additional 12,000 SF building. Management flags this as a strategic-buyers-only sale requiring existing chemical blending or distribution holdings.

Why we like it

Earnings quality is solid with $1.095M SDE and $945k EBITDA on $5.09M revenue, a healthy 18.6% EBITDA margin for a manufacturer. The book is anchored by long-tenured distributor relationships (top 10 averaging 13-plus years) and proprietary formulations that create recurring reorder behavior rather than one-off project revenue.
The moat is real and layered: proprietary formulas, custom private-label packaging, regulatory-compliant in-house label design, and decades of personal relationships. A new supplier cannot quickly reverse-engineer a distributor's private-label chemistry and packaging, which is exactly why several accounts have stuck around for 30-plus years.
This is a consolidation story with tailwind. Two competitors exited in 2024-2025 and the company is capturing their orphaned accounts at minimal incremental cost, while a growing oilfield segment adds new demand. Being one of the last independent wholesale I&I manufacturers in the region is a durable structural advantage.
The operator advantage is unusually clean: the business runs at or near full capacity on a single shift with a defined path to roughly double output via a second shift, no new facility capital required. That means a buyer can grow into existing fixed costs, expanding margins rather than just revenue.
Cleaning chemicals for food service, laundry, and industrial sanitation are consumable necessities, not discretionary spend. Restaurants, hospitals, and laundries buy these compounds in every economic climate, giving the revenue base genuine recession resilience.

How to improve it

Add a commissioned outside salesperson to systematically pursue distributor accounts across Texas, Oklahoma, Arkansas, Louisiana, and New Mexico. The current lead engine is purely referral and tradeshow, which leaves an entire proactive channel untapped and would convert the second-shift capacity into revenue.
Launch the second production shift to capitalize on the competitor closures. The orphaned accounts are already flowing in and capacity is the constraint, so scheduling incremental labor is the single fastest lever to convert existing demand into cash flow without capex.
Aggressively pursue the oilfield segment, which is already generating multiple orders per month and growing fast. Dedicate formulation and sales attention here to turn a 15% slice into a leading growth vertical while the energy cycle supports demand.
Expand custom co-packing and contract manufacturing by actively marketing private-label capabilities to national brands. This channel monetizes existing tanks and fill lines, and co-packing contracts tend to be sticky and high-volume, improving asset utilization.
Deepen wallet share on the 40-plus new products introduced in 2025 with existing distributor accounts. Cross-selling proven formulations to a loyal base is lower-risk revenue than net-new logo acquisition and lifts revenue per account.
Evaluate constructing the additional 12,000 SF building on the existing land parcel once second-shift demand is proven. Sequencing capacity expansion after demand confirmation protects the downside while removing the throughput ceiling permanently.
Reduce top-10 concentration (68% of revenue) by growing the long tail of 104 smaller accounts. Formalizing a reorder and account-management cadence for these customers diversifies the book and lifts enterprise value at exit.
Document and systematize the proprietary formulation library and QC procedures during the transition year. Codifying the founder's chemistry knowledge de-risks the single biggest key-person dependency and makes the asset far more financeable and defensible.

Diligence notes

Scrutinize the real estate structure carefully. The building is NOT included in the $7M asking price; the owner will lease it at $22,000/month plus NNN (about $264k annual rent) or sell it separately, and a bank appraisal put the property above $4M. That rent is a real, recurring drag on the $1.095M SDE that must be modeled into go-forward cash flow.
Validate the competitor-closure tailwind with hard numbers. Quantify exactly how much revenue came from orphaned accounts in 2024-2025 versus organic base, confirm those accounts are contracted or reordering consistently, and assess whether the surge is durable or a one-time bolus that will normalize.
Test customer concentration and formulation ownership. Top 10 are 68% of revenue with the largest at 14.4%; confirm the proprietary formulas and private-label rights transfer cleanly with the sale, and understand which formulations are owned by the company versus the customer in co-packing arrangements.
Assess the key-person and employee risk. The owner holds 37 years of relationships and deep formulation knowledge, and the business relies on consulting chemists plus a 12-person team. Confirm the production manager, office manager, and chemists will stay, and structure retention and a meaningful transition period given the strategic-buyer-only requirement.
Review the SDE-to-EBITDA bridge and normalization adjustments. With $1.095M SDE and $945k EBITDA, verify what add-backs are being applied, that owner compensation is realistic for a strategic buyer's org structure, and that the numbers reconcile to tax returns across multiple years.
Confirm environmental, regulatory, and insurance exposure. This is chemical manufacturing with zoned storage, so review permits, waste handling, OSHA and EPA compliance history, product liability coverage, and any historical spills or violations that could carry tail liability to a buyer.

Source

Originally listed on BizBuySell. View original listing →